Okada, Kensuke
Seki, Morinobu
Yaguchi, Hiroshi
Sakuta, Kenichi
Mukai, Taiji
Yamada, Satoshi
Oki, Koichi
Nakahara, Jin
Suzuki, Shigeaki https://orcid.org/0000-0003-4388-4574
Funding for this research was provided by:
JSPC KAKENHI (JP20H03592)
Article History
Received: 19 July 2020
Revised: 29 August 2020
Accepted: 2 September 2020
First Online: 9 September 2020
Compliance with ethical standards
:
: KeO, MS, HY, KS, TM, SY, KoO, and JN declare no competing interests. SS is a consultant/advisory board member on neurologic side effects for Ono Pharmaceutical, Bristol-Myers Squibb, MSD, Chugai, and Astra Zeneca. Outside of the submitted work, SS reports personal fees from Ono Pharmaceutical, Bristol-Myers Squibb, MSD, Chugai, and Astra Zeneca.
: This study was approved by the Institutional Review Boards of the Keio University (No. 20090278).
: Approved.
: Approved.